Isomorphic Labs is an Alphabet company that reimagines drug discovery by leveraging computational and AI-first approaches. The organization aims to accelerate the speed, increase the efficacy, and reduce the cost of drug development processes, ultimately making transformative impacts on global health. It focuses on creating a multidisciplinary environment where experts in machine learning, biology, and chemistry collaborate to push the boundaries of scientific innovation. Isomorphic Labs values thoughtfulness, bravery, determination, and collaboration, fostering a culture that emphasizes rigorous scientific inquiry and inclusive teamwork. By prioritizing diverse perspectives and expertise, the company strives to make meaningful advances in tackling complex health challenges and bringing new therapies to market.